On October 9, Humana rose 16.42% in regular trading, trading at $438.885 per share, with Turnover of $172 million.

The move followed the company's reaffirmation of its full-year 2026 adjusted earnings outlook of at least $9 per share, alongside better-than-expected 2027 Medicare Advantage Star Ratings data. Humana expects average Stars revenue per member per month of $160 in 2027, a figure it said exceeds its target of Top Quartile results and stands 10% above the peer-group median.

Shares had already jumped more than 13% in pre-market activity after the Star Ratings release. Earlier in the day, Baird upgraded Humana to Outperform with a price target of $596, while Cantor Fitzgerald and other firms have also lifted targets recently. Humana operates as a health and well-being company in the United States, with Insurance and CenterWell segments providing Medicare, Medicaid, and supplemental health benefits.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)